Step Right: Top Orthopedic Sandal Brands for Ultimate Comfort

Orthopedic sandals have gained popularity in recent years due to their ability to provide both comfort and support for everyday wear. With a growing awareness about foot health, many individuals are seeking footwear that not only looks good but also promotes proper alignment and reduces strain on the feet. The market is saturated with numerous brands claiming to offer the best in orthopedic support, making it quite challenging to choose the right pair. To help you make an informed decision, we have compiled a list of some of the best brands known for their quality and comfort below.

Illustration of orthopedic sandals

Best brands of orthopedic sandals in 2025

Birkenstock

Birkenstock, a 250-year-old German brand, has established itself as a leading producer of orthopedic sandals, renowned for their superior quality and comfort. The brand's revenue increased by 20% in fiscal 2023, driven by a 6% rise in unit sales and a 14% increase in average selling price, largely due to the popularity of premium products like the $160 Boston clogs. Birkenstock's intentional approach to product scarcity and disciplined distribution has boosted its desirability and margins. The brand's orthopedic footbeds, featuring contoured designs and natural materials, ensure proper foot health by evenly distributing weight and reducing pressure points. With a strong presence in over 90 countries, Birkenstock continues to expand its market, particularly in the U.S., where it has seen a 21% year-over-year revenue increase.

Vionic

Vionic is a leading brand in the orthopedic footwear market, particularly renowned for its innovative orthopedic sandals that offer enhanced arch support and biomechanical design. In May 2024, Vionic launched new orthopedic sandals targeting active lifestyles, reflecting the brand's commitment to comfort and therapeutic qualities. Vionic's products are recommended by healthcare professionals, which strengthens their credibility and market presence. The brand is part of a market that is expected to grow at a CAGR of 10.8% from 2024 to 2033, reaching a forecasted revenue of $12.8 billion by 2033. Vionic's focus on quality and innovation helps maintain its competitive edge in the orthopedic footwear sector. For more information on Vionic's market position and details about their innovative designs, visit their official company profile.

Orthofeet

Orthofeet is a leading brand in the orthopedic footwear market, known for its advanced orthopedic technology that promotes foot health and relieves pain. Established in 1984, Orthofeet offers a wide range of orthopedic sandals and shoes that provide exceptional comfort, support, and style, making them ideal for individuals with conditions such as plantar fasciitis, arthritis, and flat feet. These sandals are designed with orthotic insoles and cushioned soles to alleviate foot pain and ensure all-day comfort, with features like slip-resistant soles for stability and safety. Orthofeet's products are highly recommended by podiatrists and have gained widespread adoption globally. The brand's commitment to comfort, function, and style has made it a preferred choice for millions of customers worldwide.

Naot

Naot is a renowned brand in the orthopedic footwear market, particularly known for its high-quality orthopedic sandals. Since its inception in 1942, Naot has been crafting footwear with superior design and comfort, using the finest raw materials like natural latex and cork. Their uniquely engineered insoles replicate the shape of the foot, providing exceptional comfort. Naot's commitment to sustainability and environmental respect adds to its appeal. The brand's products are popular globally, with a strong presence in various markets.

Mephisto

Mephisto, founded in 1965 by Martin Michaeli, is a renowned brand in the orthopedic footwear market, particularly known for its high-quality and comfortable sandals. The brand has innovated several technologies, such as the SOFT-AIR TECHNOLOGY, which integrates soft-air latex foam and a robust outsole to enhance walking comfort. Mephisto's products are popular globally, with the brand being represented in 86 countries and generating 80% of its sales from exports. In the orthopedic footwear market, Mephisto is one of the key players, contributing to the market's growth, which is expected to reach USD 12.8 billion by 2033 with a CAGR of 10.8%.

Dr. Comfort

Dr. Comfort is a leading brand in the orthopedic footwear market, particularly renowned for its high-quality orthopedic sandals. The brand is part of the major players driving the market growth, with the orthopedic footwear market expected to grow at a CAGR of 5.2% from 2023 to 2030, reaching $18.5 billion by 2030. Dr. Comfort's products cater to various indications, including diabetes, neuromuscular and musculoskeletal disorders, and sports injuries, making them a preferred choice for consumers seeking therapeutic and comfortable footwear. The brand's presence in both offline and online distribution channels enhances its accessibility, contributing to its strong market position. With a focus on providing support, stability, and shock absorption, Dr. Comfort's orthopedic sandals are highly recommended for individuals with foot-related issues.

Aetrex

Aetrex Worldwide is a leading producer of orthopedic sandals, renowned for its high-quality and premium foot orthotics. The company is expected to benefit from the growing orthopedic shoes market, which is projected to reach USD 7.03 billion by 2032, with a CAGR of 9.16%. Aetrex's products cater to various needs, including customized orthotic insoles, which are anticipated to grow at a CAGR of 6.9% from 2024 to 2029. The increasing prevalence of foot disorders and the rising geriatric population are key drivers for the market, with 1 in 6 people worldwide expected to be aged 60 years or over by 2030. Aetrex's commitment to fashion, function, and quality positions it as a top choice in the orthopedic footwear industry. For more details, visit their official page on CB Insights.

FitFlop

FitFlop is a leading brand in the footwear industry, renowned for its biomechanically engineered sandals that offer both style and comfort. With a strong brand recognition, over 65% of targeted consumers recognize FitFlop as a leader in the wellness footwear category. The company has seen significant growth, with e-commerce sales accounting for 48% of total revenue, amounting to approximately $45 million and a year-over-year growth of 25% in the e-commerce segment. FitFlop's products, such as the iQushion™ and Microwobbleboard™ lines, achieve profit margins ranging from 20% to 30% and have received the APMA Seal of Acceptance for promoting good foot health. The brand's Net Promoter Score (NPS) of 74, significantly higher than the industry average, reflects strong customer loyalty. For a detailed analysis of their market position, you can visit FitFlop's BCG Matrix overview.

OOFOS

OOFOS is a leading brand in the recovery footwear market, renowned for its innovative OOfoam(tm) technology that absorbs 37% more impact than traditional foam, reducing stress on joints and enhancing mobility. Founded in 2011, OOFOS has achieved significant growth, including an 82% year-over-year sales increase and holding 73% of the recovery footwear market share. The brand's products are designed to aid in active recovery, making them a favorite among athletes and fitness enthusiasts. OOFOS has also recently completed a growth investment round led by notable sports figures, further solidifying its position in the market. With a projected global recovery footwear market growth at a CAGR of 9.1% from 2024 to 2033, OOFOS is well-positioned for continued success. For more information, visit their official website.

Propet

Propet is a leading brand in the orthopedic footwear market, particularly renowned for its high-quality orthopedic sandals. The brand is part of the broader orthopedic footwear market, which is expected to grow at a CAGR of 5.2% from 2023 to 2030, reaching $18.5 billion by 2030. Propet's products cater to various indications, including diabetes, arthritis, and flat feet, with the diabetes & edema segment being a significant contributor, expected to reach $5176.39 million by 2028. The brand's commitment to comfort and orthopedic support aligns with the increasing global awareness of orthopedic diseases and the need for appropriate footwear. Propet's presence in the market is bolstered by its inclusion among major players such as DARCO, Dr. Comfort, and Mephisto.